tella

About:

tella is a biotechnology company providing dendritic cell vaccine therapy for cancer treatment.

Website: https://www.tella.jp

Top Investors: UTEC - The University of Tokyo Edge Capital Partners, DBJ Capital, Yazaki Yuichiro, Okamoto Masato

Description:

tella is a biotechnology company providing dendritic cell vaccine therapy for cancer treatment.

Total Funding Amount:

474M JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2004-06-24

Founders:

Number of Employees:

11-50

Last Funding Date:

2011-01-01

IPO Status:

Private

Industries: